RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+65.81%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$2.65B
AUM Growth
+$2.65B
(+58%)
Cap. Flow
+$209M
Cap. Flow
% of AUM
7.89%
Top 10 Holdings %
Top 10 Hldgs %
54.64%
Holding
73
New
13
Increased
31
Reduced
10
Closed
12
Top Buys
| 1 |
Immunovant
IMVT
|
$66M |
| 2 |
Q32 Bio
QTTB
|
$39.3M |
| 3 |
Relmada Therapeutics
RLMD
|
$25.9M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$25.7M |
| 5 |
Korro Bio
KRRO
|
$21.8M |
Top Sells
| 1 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$39.5M |
| 2 |
Sarepta Therapeutics
SRPT
|
$15.3M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$14.9M |
| 4 |
QuidelOrtho
QDEL
|
$10.8M |
| 5 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
$9.95M |
Sector Composition
| 1 | Healthcare | 94.97% |
| 2 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rocket Pharmaceuticals
RCKT
$354M
| $383M | 14.44% | 16,812,491 +225,000 | +1% | +$5.12M |
|
|
2
Alnylam Pharmaceuticals
ALNY
$58.5B
| $189M | 7.12% | 1,637,864 -129,764 | -7% | -$14.9M |
|
3
PTC Therapeutics
PTCT
$3.92B
| $184M | 6.95% | 3,832,480 +181,119 | +5% | +$8.7M |
|
|
DRNA
4
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $129M | 4.88% | 5,874,229 -328,196 | -5% | -$7.23M |
|
5
Axsome Therapeutics
AXSM
$6.05B
| $106M | 4% | 1,026,813 +180,692 | +21% | +$18.7M |
|
6
Bristol-Myers Squibb
BMY
$96B
| $105M | 3.98% | 1,642,951 +77,644 | +5% | +$4.98M |
|
7
Stoke Therapeutics
STOK
$1.08B
| $100M | 3.79% | 3,544,248 +188,782 | +6% | +$5.35M |
|
|
8
Q32 Bio
QTTB
$20.9M
| $90M | 3.4% | 4,349,250 +1,899,772 | +78% | +$39.3M |
|
|
MRTX
9
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $83.2M | 3.14% | 645,427 +52,651 | +9% | +$6.78M |
|
|
10
Sarepta Therapeutics
SRPT
$1.78B
| $78.2M | 2.95% | 605,762 -118,549 | -16% | -$15.3M |
|
11
Adverum Biotechnologies
ADVM
$64.6M
| $73.6M | 2.78% | 6,386,607 +105,604 | +2% | +$1.22M |
|
|
12
Immunovant
IMVT
$2.56B
| $66M | 2.49% | +4,426,106 | New | +$66M |
|
13
Zimmer Biomet
ZBH
$21B
| $65.5M | 2.47% | 437,385 +34,385 | +9% | +$5.15M |
|
14
Milestone Pharmaceuticals
MIST
$156M
| $63.4M | 2.39% | 3,958,264 +436,408 | +12% | +$6.99M |
|
15
Masimo
MASI
$7.59B
| $60.4M | 2.28% | 382,187 +11,032 | +3% | +$1.74M |
|
16
Establishment Labs
ESTA
$1.2B
| $56.2M | 2.12% | 2,032,446 -7,235 | -0.4% | -$200K |
|
|
MYOK
17
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $55.5M | 2.09% | 760,988 +35,963 | +5% | +$2.62M |
|
18
Vericel Corp
VCEL
$1.83B
| $52M | 1.96% | 2,989,429 +343,953 | +13% | +$5.98M |
|
19
ProQR Therapeutics
PRQR
$237M
| $47.4M | 1.79% | 4,779,135 +1,078,302 | +29% | +$10.7M |
|
|
AXNX
20
DELISTED
Axonics, Inc. Common Stock
AXNX
| $44.1M | 1.66% | 1,591,632 +57,027 | +4% | +$1.58M |
|
|
ACHN
21
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $44.1M | 1.66% | 7,309,383 -6,555,000 | -47% | -$39.5M |
|
|
BLU
22
DELISTED
BELLUS Health Inc.
BLU
| $36.6M | 1.38% | 4,840,992 +662,836 | +16% | +$5.01M |
|
|
AGEN
23
Agenus
AGEN
$133M
| $36.1M | 1.36% | 8,876,391 -336,800 | -4% | -$1.37M |
|
24
Apyx Medical
APYX
$75.3M
| $28.7M | 1.08% | 3,391,279 +21,000 | +0.6% | +$178K |
|
|
DMTK
25
DELISTED
DermTech, Inc. Common Stock
DMTK
| $28.4M | 1.07% | 2,386,871 | – | – |
|